Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
18F-FAZA PET Imaging in Various Cancers
NCT00323076Phase 2Terminated
- Sponsor
- American Health Staffing Group
- Start
- Sep 2006
- Primary completion
- Feb 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Fluoroazomycin arabinoside F-18 in renal cell carcinoma (RCC), Neuroendocrine Neoplasm (NEN), squamous cell carcinoma of the head and neck (HNSCC), non-small cell lung carcinoma (NSCLC), Small Cell Lung Cancer (SCLC), sponsored by American Health Staffing Group. Started Sep 2006; status: terminated.
02
Drugs
Fluoroazomycin arabinoside F-18
03
Conditions
renal cell carcinoma (RCC)Neuroendocrine Neoplasm (NEN)squamous cell carcinoma of the head and neck (HNSCC)non-small cell lung carcinoma (NSCLC)Small Cell Lung Cancer (SCLC)
Beyond the preview
Go deeper on NCT00323076.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00323076.